These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 13165997)

  • 21. [About recent therapies for urinary calcium calculus].
    GENOT R
    J Urol Medicale Chir; 1955; 61(5):340-5. PubMed ID: 13307728
    [No Abstract]   [Full Text] [Related]  

  • 22. Urinary risk factors for recurrent calcium stone formation in Thai stone formers.
    Stitchantrakul W; Kochakarn W; Ruangraksa C; Domrongkitchaiporn S
    J Med Assoc Thai; 2007 Apr; 90(4):688-98. PubMed ID: 17487123
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Studies on urine stabilization by hyaluronidase, hyaluronic acid and dextran].
    VOIT E; HIRSCH HH
    Klin Wochenschr; 1955 Sep; 33(33-34):806-8. PubMed ID: 13264540
    [No Abstract]   [Full Text] [Related]  

  • 24. [The most important factor for active urinary stone formation in patients with urolithiasis].
    Simić-Ogrizović S; Dopsaj V; Jovicić S; Milenković D; Jovanović D; Nesić V
    Med Pregl; 2007; 60 Suppl 2():117-20. PubMed ID: 18928175
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bilateral upper urinary tract calculi in an infant.
    MAGID MA; HEJTMANCIK JH
    Trans South Cent Sect Am Urol Assoc; 1954; 49():136-9. PubMed ID: 14373875
    [No Abstract]   [Full Text] [Related]  

  • 26. Extravasation of urine after irrigation of the bladder with hyaluronidase.
    LAURENCE KM; EADIE JW
    Lancet; 1954 Oct; 267(6841):736-7. PubMed ID: 13202486
    [No Abstract]   [Full Text] [Related]  

  • 27. Proteomics and detection of uromodulin in first-time renal calculi patients and recurrent renal calculi patients.
    Wai-Hoe L; Wing-Seng L; Ismail Z; Lay-Harn G
    Appl Biochem Biotechnol; 2009 Oct; 159(1):221-32. PubMed ID: 19145410
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Urinary lithogenesis and its relation to the mesenchymal physiopathology].
    LI VOTI P
    Minerva Urol; 1953; 5(6):248-54. PubMed ID: 13154144
    [No Abstract]   [Full Text] [Related]  

  • 29. Lemonade therapy increases urinary citrate and urine volumes in patients with recurrent calcium oxalate stone formation.
    Penniston KL; Steele TH; Nakada SY
    Urology; 2007 Nov; 70(5):856-60. PubMed ID: 17919696
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reduced renal function and benefits of treatment in cystinuria vs other forms of nephrolithiasis.
    Worcester EM; Coe FL; Evan AP; Parks JH
    BJU Int; 2006 Jun; 97(6):1285-90. PubMed ID: 16686727
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison between lemonade and potassium citrate and impact on urine pH and 24-hour urine parameters in patients with kidney stone formation.
    Koff SG; Paquette EL; Cullen J; Gancarczyk KK; Tucciarone PR; Schenkman NS
    Urology; 2007 Jun; 69(6):1013-6. PubMed ID: 17572176
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Place of the new therapeutics in the treatment of phosphorus and calcium urinary lithiasis].
    GENOT R
    Presse Med (1893); 1955 Jun; 63(45):932-4. PubMed ID: 14395181
    [No Abstract]   [Full Text] [Related]  

  • 33. Observations on the effect of hyaluronidase on urinary calculi.
    NARINS L; SIMON N; OPPENHEIMER GD
    J Mt Sinai Hosp N Y; 1948; 15(1):33-7. PubMed ID: 18866227
    [No Abstract]   [Full Text] [Related]  

  • 34. Factors affecting the regrowth of renal stones in vitro: a contribution to the understanding of renal stone development.
    Costa-Bauzá A; Isern B; Perelló J; Sanchis P; Grases F
    Scand J Urol Nephrol; 2005; 39(3):194-9. PubMed ID: 16118089
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Identification of lithogenic risk factors by a simplified first-line laboratory assessment in urinary calculi patients].
    Glémain P; Prunet D
    Prog Urol; 2006 Nov; 16(5):542-5. PubMed ID: 17175947
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pediatric urinary stone disease--does age matter?
    Kalorin CM; Zabinski A; Okpareke I; White M; Kogan BA
    J Urol; 2009 May; 181(5):2267-71; discussion 2271. PubMed ID: 19296968
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Associations between renal sodium-citrate cotransporter (hNaDC-1) gene polymorphism and urinary citrate excretion in recurrent renal calcium stone formers and normal controls.
    Okamoto N; Aruga S; Matsuzaki S; Takahashi S; Matsushita K; Kitamura T
    Int J Urol; 2007 Apr; 14(4):344-9. PubMed ID: 17470169
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Body size and 24-hour urine composition.
    Taylor EN; Curhan GC
    Am J Kidney Dis; 2006 Dec; 48(6):905-15. PubMed ID: 17162145
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Jejunoileal bypass reversal: effect on renal function, metabolic parameters and stone formation.
    Dhar NB; Grundfest S; Jones JS; Streem SB
    J Urol; 2005 Nov; 174(5):1844-6; discussion 1846. PubMed ID: 16217311
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Changes in urinary stone risk factors in hypocitraturic calcium oxalate stone formers treated with dietary sodium supplementation.
    Stoller ML; Chi T; Eisner BH; Shami G; Gentle DL
    J Urol; 2009 Mar; 181(3):1140-4. PubMed ID: 19152919
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.